Verition Fund Management’s Sanofi SNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.77M Buy
+65,000
New +$2.9M 0.01% 944
2026
Q1
Sell
-38,942
Closed -$1.89M 3433
2025
Q4
$1.89M Buy
38,942
+33,236
+582% +$1.65M 0.01% 1659
2025
Q3
$269K Buy
+5,706
New +$275K ﹤0.01% 3347
2025
Q2
Sell
-29,306
Closed -$1.63M 3845
2025
Q1
$1.63M Buy
+29,306
New +$1.59M 0.01% 1727
2024
Q3
Sell
-12,213
Closed -$593K 3492
2024
Q2
$593K Buy
+12,213
New +$589K ﹤0.01% 1965
2015
Q1
Sell
-38,489
Closed -$1.75M 492
2014
Q4
$1.75M Buy
+38,489
New +$1.87M 0.39% 37
2013
Q4
Sell
-11,789
Closed -$597K 652
2013
Q3
$597K Buy
+11,789
New +$600K 0.09% 179

Other funds holding SNY

Verition Fund Management's SNY Position: Q2 2026 in Review

Verition Fund Management opened a new position in Sanofi (SNY) in Q2 2026: 65,000 shares worth $2.77M. The stake represents 0.01% of the portfolio and ranks #944 among its holdings. This is a return to the name: Verition Fund Management previously reported a position in SNY as recently as Q4 2025.

Verition Fund Management first reported a position in SNY in Q3 2013 and has held it in 7 quarters since. 716 funds tracked by Wall St. Rank hold SNY as of Q2 2026.

  • Verition Fund Management held 65,000 shares of Sanofi worth $2.77M as of Q2 2026.
  • Sanofi was a new Verition Fund Management position in Q2 2026.
  • Sanofi made up 0.01% of Verition Fund Management's portfolio in Q2 2026, its #944 holding.
  • Verition Fund Management first reported a position in Sanofi in Q3 2013 and has held it in 7 quarters since.
  • 716 funds tracked by Wall St. Rank held Sanofi as of Q2 2026.

Based on Verition Fund Management's 13F filing for Q2 2026, filed 14 Aug 2026.